Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 8 November 2023, Jónas Einarsson, a primary insider and chair of the board of the Company, has today bought 5,300 shares in the company at an average price of NOK 93.95 per share. Following this transaction, Jónas Einarsson hold 5,300 shares in Ultimovacs ASA.
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Upcoming Life Sciences Events
- March 2024
- Zurich: Swiss Nordic Bio 2024
- RRb: Why and How Rural Biotech Can Compete with Urban Hubs
- Barcelona: BIO-Europe Spring® 2024
Latest company news
There are currently no news available for this portal